Celcuity (NASDAQ: CELC), a clinical-stage biotechnology company focused on developing targeted oncology therapies, has scheduled its second quarter 2025 financial results release for Thursday, August 14, 2025 after market close.
Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. Investors can access the call via phone (domestic: 1-800-717-1738, international: 1-646-307-1865) or through a live webcast. A replay will be available on Celcuity's website after the event.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.